"Integrin beta1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Integrin beta chain expressed as a heterodimer that is non-covalently associated with specific alpha-chains of the CD49 family (CD49a-f). It is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164)
| Descriptor ID |
D019012
|
| MeSH Number(s) |
D12.776.543.750.705.408.200.500
|
| Concept/Terms |
Integrin beta1- Integrin beta1
- CD29 Antigen
- Antigen, CD29
- CD29 Antigens
- beta1 Integrin
- Integrin, beta1
- 4B4 Antigen
- Antigen, 4B4
- CDw29 Antigen
- Antigen, CDw29
- Antigens, CD29
|
Below are MeSH descriptors whose meaning is more general than "Integrin beta1".
Below are MeSH descriptors whose meaning is more specific than "Integrin beta1".
This graph shows the total number of publications written about "Integrin beta1" by people in this website by year, and whether "Integrin beta1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 2 | 3 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Integrin beta1" by people in Profiles.
-
Mapping the placental galectin-3 interactome identifies CD9 and ITGB1 as functional glycoprotein counterreceptors during syncytialization. Proc Natl Acad Sci U S A. 2025 Nov 11; 122(45):e2511042122.
-
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
-
A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis. Clin Cancer Res. 2020 06 01; 26(11):2711-2724.
-
Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity. Blood Adv. 2018 12 11; 2(23):3540-3552.
-
ß1-integrin restricts astrocytic differentiation of adult hippocampal neural stem cells. Glia. 2016 07; 64(7):1235-51.
-
The interaction of Ga13 with integrin ß1 mediates cell migration by dynamic regulation of RhoA. Mol Biol Cell. 2015 Oct 15; 26(20):3658-70.
-
Astrocytic ß1-integrin affects cellular composition of murine blood brain barrier in the cerebral cortex. Int J Dev Neurosci. 2015 Aug; 44:48-54.
-
Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate. Breast Cancer Res Treat. 2013 Dec; 142(3):537-48.
-
aV-integrins are required for mechanotransduction in MDCK epithelial cells. PLoS One. 2013; 8(8):e71485.
-
ß1 integrin is a crucial regulator of pancreatic ß-cell expansion. Development. 2013 Aug; 140(16):3360-72.